Table 2.
Gene | Model | Optimal Threshold |
AUC (95%CI) | FN / FP / TP / TN | MCC |
---|---|---|---|---|---|
BRCA1 | NVM-Validation | ≥9 | 0.94 (0.897–0.983) | 5 / 8 / 25 / 79 | 0.719 |
Vest3RankScore | ≥0.85546 | 0.9 (0.849–0.95) | 8 / 24 / 51 / 153 | 0.678 | |
Vest3Score | ≥0.868 | 0.9 (0.849–0.95) | 8 / 24 / 51 / 153 | 0.678 | |
RF | ≥0.298 | 0.92 (0.879–0.96) | 8 / 26 / 51 / 151 | 0.663 | |
AlignGVGDPrior | ≥0.29 | 0.88 (0.829–0.931) | 7 / 37 / 54 / 150 | 0.614 | |
PERCHnoMAF | ≥0.206316 | 0.87 (0.814–0.924) | 10 / 31 / 51 / 156 | 0.614 | |
PERCH | ≥0.239853 | 0.87 (0.819–0.922) | 10 / 32 / 51 / 155 | 0.607 | |
Polyphen2HvarRankScore | ≥0.91584 | 0.89 (0.845–0.93) | 11 / 30 / 48 / 147 | 0.593 | |
Polyphen2HvarScore | ≥0.999 | 0.89 (0.845–0.93) | 11 / 30 / 48 / 147 | 0.593 | |
MetaSVMRankScore | ≥0.9083 | 0.89 (0.844–0.928) | 11 / 34 / 48 / 143 | 0.565 | |
BRCA2 | NVM-Validation | ≥4 | 0.89 (0.826–0.963) | 6 / 9 / 29 / 59 | 0.683 |
PERCH | ≥0.295957 | 0.89 (0.847–0.939) | 11 / 21 / 60 / 115 | 0.672 | |
PERCHnoMAF | ≥0.272149 | 0.88 (0.832–0.929) | 12 / 23 / 59 / 113 | 0.642 | |
RFModel | ≥0.371 | 0.9 (0.843–0.947) | 12 / 24 / 59 / 111 | 0.633 | |
MetaSVMRankScore | ≥0.93181 | 0.87 (0.824–0.923) | 15 / 29 / 56 / 107 | 0.555 | |
MetaSVMScore | ≥0.7002 | 0.87 (0.824–0.923) | 15 / 29 / 56 / 107 | 0.555 | |
MetaLRRankScore | ≥0.92107 | 0.87 (0.823–0.922) | 16 / 30 / 55 / 106 | 0.535 | |
MetaLRScore | ≥0.7679 | 0.87 (0.823–0.922) | 16 / 30 / 55 / 106 | 0.535 | |
Vest3RankScore | ≥0.79963 | 0.83 (0.776–0.893) | 16 / 30 / 55 / 106 | 0.535 | |
Vest3Score | ≥0.811 | 0.83 (0.776–0.893) | 16 / 30 / 55 / 106 | 0.535 |
FN: False negative; FP: False positive; TP: True positive; TN: True negative
AUC: Area under the curve from Receiver Operator characteristic analysis
MCC: Matthew Correlation Coefficient